Dow Jones

39,400.30

0.60%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
AMEX
Lorus Therapeutics, (New) (LRP)
Lorus Therapeutics, (New) (LRP) News

Lorus Therapeutics (LRP)

Lorus Therapeutics, (New)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:LRP

1 2 3 4 5 6 7 Next >>

Date	Time	Source	Headline	Symbol	Company
21/10/2014	13:00	PR Newswire (US)	Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO	AMEX:LRP	Lorus Therapeutics, (New)
21/10/2014	13:00	PR Newswire (Canada)	Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO	AMEX:LRP	Lorus Therapeutics, (New)
03/10/2014	12:00	PR Newswire (US)	Aptose Biosciences to Present at the 2014 BIO Investor Forum	AMEX:LRP	Lorus Therapeutics, (New)
03/10/2014	12:00	PR Newswire (Canada)	Aptose Biosciences to Present at the 2014 BIO Investor Forum	AMEX:LRP	Lorus Therapeutics, (New)
01/10/2014	22:16	PR Newswire (Canada)	Aptose Biosciences Announces Reverse Stock Split	AMEX:LRP	Lorus Therapeutics, (New)
01/10/2014	22:16	PR Newswire (US)	Aptose Biosciences Announces Reverse Stock Split	AMEX:LRP	Lorus Therapeutics, (New)
29/09/2014	13:30	PR Newswire (US)	Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...	AMEX:LRP	Lorus Therapeutics, (New)
29/09/2014	13:30	PR Newswire (Canada)	Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...	AMEX:LRP	Lorus Therapeutics, (New)
25/09/2014	14:48	PR Newswire (US)	Aptose Biosciences to Present at Upcoming Investor Conferences	AMEX:LRP	Lorus Therapeutics, (New)
25/09/2014	14:48	PR Newswire (Canada)	Aptose Biosciences to Present at Upcoming Investor Conferences	AMEX:LRP	Lorus Therapeutics, (New)
08/09/2014	12:00	PR Newswire (US)	Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer	AMEX:LRP	Lorus Therapeutics, (New)
08/09/2014	12:00	PR Newswire (Canada)	Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer	AMEX:LRP	Lorus Therapeutics, (New)
02/09/2014	12:00	PR Newswire (US)	Lorus Therapeutics Implements Name Change to Aptose Biosciences	AMEX:LRP	Lorus Therapeutics, (New)
02/09/2014	12:00	PR Newswire (Canada)	Lorus Therapeutics Implements Name Change to Aptose Biosciences	AMEX:LRP	Lorus Therapeutics, (New)
19/08/2014	21:00	PR Newswire (US)	Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders	AMEX:LRP	Lorus Therapeutics, (New)
19/08/2014	21:00	PR Newswire (Canada)	Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders	AMEX:LRP	Lorus Therapeutics, (New)
07/08/2014	12:00	PR Newswire (US)	Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference	AMEX:LRP	Lorus Therapeutics, (New)
07/08/2014	12:00	PR Newswire (Canada)	Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference	AMEX:LRP	Lorus Therapeutics, (New)
28/07/2014	12:00	PR Newswire (US)	Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo...	AMEX:LRP	Lorus Therapeutics, (New)
28/07/2014	12:00	PR Newswire (Canada)	Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo...	AMEX:LRP	Lorus Therapeutics, (New)
15/07/2014	21:46	PR Newswire (US)	Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014	AMEX:LRP	Lorus Therapeutics, (New)
15/07/2014	21:46	PR Newswire (Canada)	Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014	AMEX:LRP	Lorus Therapeutics, (New)
15/07/2014	21:28	PR Newswire (US)	Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing	AMEX:LRP	Lorus Therapeutics, (New)
15/07/2014	21:28	PR Newswire (Canada)	Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing	AMEX:LRP	Lorus Therapeutics, (New)
10/07/2014	12:00	PR Newswire (US)	Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast	AMEX:LRP	Lorus Therapeutics, (New)
10/07/2014	12:00	PR Newswire (Canada)	Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast	AMEX:LRP	Lorus Therapeutics, (New)
19/06/2014	12:00	PR Newswire (US)	Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference	AMEX:LRP	Lorus Therapeutics, (New)
19/06/2014	12:00	PR Newswire (Canada)	Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference	AMEX:LRP	Lorus Therapeutics, (New)
16/06/2014	12:00	PR Newswire (Canada)	Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference	AMEX:LRP	Lorus Therapeutics, (New)
16/06/2014	12:00	PR Newswire (US)	Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference	AMEX:LRP	Lorus Therapeutics, (New)